|
Initial
Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
[Sterling TR, et al. NEJM 2001;344:720]
posted 3/29/2001
Correlates
of Mother-to-Child Human Immunodeficiency Virus Type 1 (HIV-1) Transmission:
Association with Maternal Plasma HIV-1 RNA Load, Genital HIV-1 DNA
Shedding, and Breast Infections [John GC, et al. JID
2001;183:206]
posted 3/29/2001
Feasibility
of Postexposure Prophylaxis (PEP) Against Human Immunodeficiency
Virus Infection After Sexual or Injection Drug Use Exposure: The
San Francisco PEP Study [Kahn JO, et al. JID 2001;183:707]
posted 3/29/2001
Indinavir,
Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency
Virus-Infected, Amprenavir-Experienced Subjects: AIDS Clinical Trials
Group Protocol 373 [Gulick RM, et al. JID 2001;183:715]
posted 3/29/2001
Survival
After AIDS Diagnosis in Adolescence and Adults During the Treatment
Era, United States, 1984 - 1997 [Lee LM, et al. JAMA
2001;285:1308]
posted 3/23/2001
Expenditures
for the Care of HIV-Infected Patients in the Era of Highly Active
Antiretroviral Therapy [Bozzette SA, et al. NEJM
2001;344:817]
posted 3/23/2001
The
Cost Effectiveness of Combination Antiretroviral Therapy for HIV
Disease [Freedberg KA, et al. NEJM 2001;344:824]
posted 3/23/2001
Use
of Genotypic Resistance Testing to Guide HIV Therapy: Clinical Impact
and Cost-Effectiveness [Weinstein MC, et al. Ann Intern
Med 2001;134:440]
posted 3/23/2001
Symptomatic
Hyperlactataemia: An Emerging Complication of Antiretroviral Therapy
[Gerard Y, et al. AIDS 2000 14:2723]
posted 3/23/2001
Prophylaxis
with a nevirapine-containing triple regimen after exposure to HIV-1
[Benn PD, et al. Lancet 2001;357:687]
posted 3/20/2001
Abacavir-lamivudine-zidovudine
vs. indinavir-lamivudine-zidovudine in antiretroviral-naïve
HIV-infected adults [Staszewski S, et al. JAMA 2001;285:1155]
posted 3/20/2001
Clinical
and laboratory guidelines for the use of HIV-1 drug resistance testing
as part of treatment management: recommendations for the European
setting [The EuroGuidelines Group for HIV Resistance. AIDS
2001;15:309]
posted 3/20/2001
Placebo-controlled
trial of prednisone in advanced HIV-1 infection [McComsey
GA, et al. AIDS 2001;15:321]
posted 3/20/2001
Effectiveness
of potent antiretroviral therapies on the incidence of opportunistic
infections before and after AIDS diagnosis [Detels R, et
al. AIDS 2001;15:347]
posted 3/20/2001
President
Bush Supports Use of Generic Versions of Expensive Drugs by Developing
Countries [Dickson D. Nature 2001;410:3]
posted 3/20/2001
Experts
debate broad drug prophylaxis policy for HIV infected in Africa
[Stencel C. ASM News 2001;67:131]
posted 3/20/2001
Multiple
Drug Rescue Therapy for HIV-Infected Individuals with Prior Virologic
Failure to Multiple Regimens [Montaner JSG, et al. AIDS
2001;15:61]
posted 3/13/2001
Efavirenz
Plasma Levels Can Predict Treatment Failure and Central Nervous
System Side Effects in HIV-1-Infected Patients [Marzolini
C, et al. AIDS 2001;15:71]
posted 3/13/2001
Reasons
for Modification and Discontinuation of Antiretrovirals: Results
from a Single Treatment Center [Mocroft A, et al. AIDS
2001; 15:185]
posted 3/13/2001
Risk
of Lipodystrophy in HIV-1-Infected Patients Treated with Protease
Inhibitors: A Prospective Cohort Study [Martinez E, et al.
Lancet 2001;357:592]
posted 3/8/2001
New
U.S. HIV-Prevention Program to Target Those Already Infected
[McCarthy M. Lancet 2001;357:613]
posted 3/8/2001
Therapy
of Efavirenz Plus Indinavir in Patients with Extensive Prior Nucleoside
Reverse Transcriptase Inhibitor Experience: A Randomized, Double-Blind,
Placebo Controlled Trial [Haas DW, et al. JID 2001;183:392]
posted 3/8/2001
ABT-378/Ritonavir
Plus Stavudine and Lamivudine for the Treatment of Antiretroviral-Naïve
Adults with HIV-1 Infection: 48-Week Results [Murphy RL,
et al. AIDS 2001;15:F1]
posted 3/8/2001
Discontinuation
of Maintenance Therapy for Cytomegalovirus Retinitis in HIV-Infected
Patients Receiving Highly Active Antiretroviral Therapy
[Jouan M, et al. AIDS 2001;15:23]
posted 3/8/2001
Virologic
and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug
Therapy in HIV-Infected Patients with Detectable Viremia
[Deeks SG, et al. NEJM 2001;344:472]
posted 3/1/2001
Perinatal
Transmission of Human Immunodeficiency Virus Type 1 by Pregnant
Women with RNA Virus Loads <1000 Copies/mL [Ioannidis
JPA, et al. JID 2001;183:539]
posted 3/1/2001
Twice-Daily
Triple Nucleoside Intensification Treatment with Lamivudine-Zidovudine
plus Abacavir Sustains Suppression of Human Immunodeficiency Virus
Type 1: Results of the TARGET Study [Henry K, et al. JID
2001;183:571]
posted 3/1/2001
Hepatitis
C Virus Load Is Associated with Human Immunodeficiency Virus Type
1 Disease Progression In Hemophiliacs [Daar ES et al. JID
2001;183:589]
posted 3/1/2001
Effect
of Highly Active Antiretroviral Therapy on Diagnoses of Sexually
Transmitted Diseases in People with AIDS [Scheer S, et al.
Lancet 2001;357:432]
posted 3/1/2001
HAART
Reduces Kaposi's Sarcoma Risk [J Natl Cancer Inst
2000;93:1823]
posted 3/1/2001
Virologic
and Regimen Termination Surrogate Endpoints in AIDS Clinical Trials
[Gilbert PB, et al. JAMA 2001;285:777]
posted 3/1/2001
|
archive